The
table below summarizes the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2025 and 2024:
SCHEDULE OF SEGMENT REPORTING INFORMATION
| |
|
2025 |
|
|
2024 |
|
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| |
|
USD in thousands |
|
| |
|
|
|
|
|
|
| Revenues |
|
|
3,015 |
|
|
|
3,964 |
|
| |
|
|
|
|
|
|
|
|
| Cost of Sales (*) |
|
|
1,934 |
|
|
|
2,730 |
|
| |
|
|
|
|
|
|
|
|
| Research and Development expenses (*) |
|
|
8,646 |
|
|
|
6,160 |
|
| |
|
|
|
|
|
|
|
|
| Sales and marketing (*) |
|
|
1,967 |
|
|
|
951 |
|
| |
|
|
|
|
|
|
|
|
| General and Administrative expenses (*) |
|
|
5,205 |
|
|
|
4,121 |
|
| |
|
|
|
|
|
|
|
|
| Other segment items: |
|
|
|
|
|
|
|
|
| Share-based compensation |
|
|
3,078 |
|
|
|
2,386 |
|
| Inventory impairment |
|
|
203 |
|
|
|
- |
|
| Depreciation |
|
|
117 |
|
|
|
123 |
|
| Finance income, net |
|
|
1,100 |
|
|
|
740 |
|
| |
|
|
|
|
|
|
|
|
| Net loss |
|
|
17,035 |
|
|
|
11,767 |
|
| (*) |
|
Excluding
share-based payments, inventory impairment, depreciation expense and finance income, net. |
|